SARS-CoV-2 CD8+ T cell killing assays using replicating viruses and transgenic antigens. Mateyka et al.

Supplementary videos of xCELLigence based target antigen killing assay of the brightfield channel overlayered with the RFP channel (2 images/second, 72h total). Uploaded are videos for competent A549-Nsp2 cells as well as of competent A549-Gaussia cells with the addition of SARS-CoV-2-specific, TCR-engineered CD8+ T cells (E:T ratio 3:1, S13 and S32).

xCELLigence 基于靶抗原杀伤检测的补充视频，该检测采用明场通道与 RFP 通道叠加（每秒 2 张图像，总计 72 小时）。所上传的视频包括具有感染能力的 A549-Nsp2 细胞的视频，以及添加了针对 SARS-CoV-2 特异性、TCR 改进的 CD8+ T 细胞（E:T 比例为 3:1，S13 和 S32）的具有感染能力的 A549-Gaussia 细胞的视频。